Science
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
Pavlo Gonchar | Lightrocket | Getty Images The Food and Drug Administration on Friday approved Pfizer‘s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S. The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B […]
Read MoreThis startup can help crops chat to farmers, reducing pesticides and agricultural squander
What if plants could speak to farmers and convey to them when they are in distress? That would not only preserve the vegetation, but it could lessen the amount of money of agricultural squander that threatens the planet’s wellbeing. A lot of agriculture may appear eco-friendly, but the marketplace is a person of the world’s […]
Read MoreWalgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy services
A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Thursday said it will start to work directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader expansion of its specialty […]
Read MoreNASA releases satellite shots of Dubai and Abu Dhabi just before and following record flooding
NASA released shots of elements of Dubai and Abu Dhabi before and just after the United Arab Emirates was hit by report rainfall previous week that prompted perilous floods and paralyzed significantly of the state. The visuals, taken by NASA Earth Observatory on Friday applying Landsat information from the U.S. Geological Study, display large patches […]
Read MoreMeet the private doctor to the wealthy — at $40,000 a year
Dr. Jordan Shlain, founder of Private Medical. Credit: Jordan Shlain A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. When people ask Dr. Jordan Shlain to describe his medical practice, he says […]
Read MoreBillionaire Kam Ghaffarian sets his sights on the stars with a range of space companies
Jeff Bezos wants to build permanent outposts on the moon and colonize space. Richard Branson wants to make spaceflight as commonplace as air travel. Elon Musk wants to settle Mars to make humanity multiplanetary. IBX’s Kam Ghaffarian wants to go even further: the stars. “There’s this common denominator of combining altruism, to do something purposeful […]
Read MoreEli Lilly’s weight loss drug Zepbound shows promise as a sleep apnea treatment in late-stage trials
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Brendan McDermid | Reuters Eli Lilly on Wednesday said its highly popular weight loss drug Zepbound showed the potential to treat patients with the most common sleep-related breathing disorder in two late-stage clinical trials. The […]
Read MoreHow the U.S. federal government is regulating synthetic intelligence
The U.S. government is considering guidelines to aid culture adapt to the introduction of synthetic intelligence. Early buyers of the technologies are previously viewing labor productivity gains. For case in point, Klarna, a acquire now, shell out later on monetary products and services company, estimates that its AI assistant resource will increase its income final […]
Read MoreConsumer microbiome startup Seed Health is rolling its profits into an AI science moonshot
A probiotic culture experiment in a laboratory. Future Publishing | Future Publishing | Getty Images Seed Health has been in the business of microbiome scientific breakthroughs since its founding in 2015, but its biggest success to-date may have been becoming profitable as a bioscience startup. The popularity of the company’s original product, DS-01, a daily […]
Read More